Related Experiment Videos
[Bone-marrow biopsy in Hodgkin's disease]
Summary
Bone marrow biopsies are crucial for detecting Hodgkin's disease spread, revealing tumors in 12.5% of cases. This investigation is recommended routinely, especially in early stages and suspected relapses.
Area of Science:
- Hematology
- Oncology
- Pathology
Context:
- Hodgkin's disease diagnosis and staging.
- Bone marrow biopsy as a diagnostic tool.
- Evaluation of hematopoietic tissue and tumor involvement.
Purpose:
- To assess the utility of bone marrow biopsies in detecting Hodgkin's disease.
- To determine the frequency and patterns of bone marrow involvement in Hodgkin's disease across different stages.
- To correlate bone marrow involvement with clinical stage, histology, and organ involvement (spleen, liver).
Summary:
- Bone marrow biopsies were performed on 349 subjects with Hodgkin's disease, with 12.5% revealing tumor presence.
- Hematopoietic tissue abnormalities were noted in non-tumor bone marrows (normal, hyperplastic, hypoplastic/aplastic).
- Tumor involvement frequency increased with clinical stage (5.4% Stage I to 47.6% Stage IV), occurring even in early stages.
- Bone marrow involvement was significantly more common in splenectomized patients with concurrent spleen or liver involvement.
- The study highlights bone marrow biopsy as a routine investigation for detecting hematogenous spread and monitoring relapses.
Impact:
- Establishes bone marrow biopsy as a key diagnostic method for Hodgkin's disease staging and relapse detection.
- Provides critical data on the incidence and patterns of bone marrow involvement, aiding treatment decisions.
- Emphasizes the importance of routine bone marrow examination in early disease stages and suspected relapses.